Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care

Advanced Drug Delivery Reviews

Volumn 78, Issue , 2014, Pages 105-117

  Mani, Vigneshwaran ^a   Wang, ShuQi ^b   Inci, Fatih ^b   De Libero, Gennaro ^a,c   Singhal, Amit ^a   Demirci, Utkan ^b  

^a AGENCY FOR SCIENCE   (Singapore)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Diagnostics; Drug resistance; Nano microscale technologies; Point of care; Tuberculosis

Indexed keywords

DEVELOPING COUNTRIES; HEALTH RISKS; PLASMA DIAGNOSTICS;

DRUG RESISTANCE; EFFECTIVE MANAGEMENT; EMERGING TECHNOLOGIES; FLUOROQUINOLONES; INFECTIOUS DISEASE; MYCOBACTERIUM TUBERCULOSIS; POINT OF CARE; TUBERCULOSIS;

DIAGNOSIS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIOPHAGE; BACTERIUM CULTURE; BACTERIUM DETECTION; BIOASSAY; CULTURE MEDIUM; DRUG RESISTANT TUBERCULOSIS; GENOTYPE; HEALTH CARE COST; HUMAN; IMMUNOSENSOR; MICROFLUIDICS; MOBILE PHONE; MOLECULAR DIAGNOSTICS; NUCLEIC ACID AMPLIFICATION; PAPER; PATIENT MONITORING; PHENOTYPE; POINT OF CARE TESTING; PORTABLE EQUIPMENT; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM EXAMINATION; TELEMEDICINE; DRUG EFFECTS; EARLY DIAGNOSIS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HOSPITAL INFORMATION SYSTEM; ISOLATION AND PURIFICATION; MICROTECHNOLOGY; MYCOBACTERIUM TUBERCULOSIS; NANOTECHNOLOGY; PROCEDURES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

TUBERCULOSTATIC AGENT;

ANTITUBERCULAR AGENTS; EARLY DIAGNOSIS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MICROTECHNOLOGY; MYCOBACTERIUM TUBERCULOSIS; NANOTECHNOLOGY; POINT-OF-CARE SYSTEMS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84919464355     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.05.015     Document Type: Review

References (91)

1. Millar B.C., Xu J., Moore J.E. Molecular diagnostics of medically important bacterial infections. Curr. Issues Mol. Biol. 2007, 9:21-39.
2. Levy S.B., Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 2004, 10:S122-S129.
3. Rice L.B. Progress and challenges in implementing the research on ESKAPE pathogens. Infect. Control Hosp. Epidemiol. 2010, 31(Suppl. 1):S7-S10.
4. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 2009, 9:228-236.
5. Sin M.L., Mach K.E., Wong P.K., Liao J.C. Advances and challenges in biosensor-based diagnosis of infectious diseases. Expert. Rev. Mol. Diagn. 2014, 14:225-244.
6. The Global Plan to Stop TB 2011-2015, WHO, StopTB Partnership.
7. Jain A., Dixit P. Multidrug-resistant to extensively drug resistant tuberculosis: what is next?. J. Biosci. 2008, 33:605-616.
8. Global Tuberculosis Control 2011, World Health Organization.
9. Global Tuberculosis Report 2012, World Health Organization, Geneva.
10. Wang S., Inci F., De Libero G., Singhal A., Demirci U. Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol. Adv. 2013, 31:438-449.
11. Nebenzahl-Guimaraes H., Jacobson K.R., Farhat M.R., Murray M.B. Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 2013, 69:331-342.
12. Lawn S.D., Dheda K., Kerkhoff A.D., Peter J.G., Dorman S., Boehme C.C., Nicol M.P. Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infect. Dis. 2013, 13:407.
13. Lawn S.D., Kerkhoff A.D., Vogt M., Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect. Dis. 2012, 12:201-209.
14. Lawn S.D., Mwaba P., Bates M., Piatek A., Alexander H., Marais B.J., Cuevas L.E., McHugh T.D., Zijenah L., Kapata N., Abubakar I., McNerney R., Hoelscher M., Memish Z.A., Migliori G.B., Kim P., Maeurer M., Schito M., Zumla A. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect. Dis. 2013, 13:349-361.
15. Acuna-Villaorduna C., Vassall A., Henostroza G., Seas C., Guerra H., Vasquez L., Morcillo N., Saravia J., O'Brien R., Perkins M.D., Cunningham J., Llanos-Zavalaga L., Gotuzzo E. Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin. Infect. Dis. 2008, 47:487-495.
16. Caviedes L., Lee T.S., Gilman R.H., Sheen P., Spellman E., Lee E.H., Berg D.E., Montenegro-James S. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J. Clin. Microbiol. 2000, 38:1203-1208.
17. Leung E., Minion J., Benedetti A., Pai M., Menzies D. Microcolony culture techniques for tuberculosis diagnosis: a systematic review. Int. J. Tuber. Lung Dis. 2012, 16:16-23. (i-iii).
18. Minion J., Leung E., Menzies D., Pai M. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect. Dis. 2010, 10:688-698.
19. Wilson S.M., al-Suwaidi Z., McNerney R., Porter J., Drobniewski F. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat. Med. 1997, 3:465-468.
20. Pai M., Kalantri S., Pascopella L., Riley L.W., Reingold A.L. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J. Infect. 2005, 51:175-187.
21. Albert H., Trollip A.P., Seaman T., Abrahams C., Mole R.J., Jordaan A., Victor T., Hoosain E. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape. S. Afr. Med. J. 2007, 97:858-863.
22. Baylan O., Kisa O., Albay A., Doganci L. Evaluation of a new automated, rapid, colorimetric culture system using solid medium for laboratory diagnosis of tuberculosis and determination of anti-tuberculosis drug susceptibility. Int. J. Tuber. Lung Dis. 2004, 8:772-777.
23. Kocagoz T., Altin S., Turkyilmaz O., Tas I., Karaduman P., Bolaban D., Yesilyurt E., Oktem S., Aytekin N., Sinik G., Mozioglu E., Silier T. Efficiency of the TK culture system in the diagnosis of tuberculosis. Diagn. Microbiol. Infect. Dis. 2012, 72:350-357.
24. Craw P., Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip 2012, 12:2469-2486.
25. Morgan M., Kalantri S., Flores L., Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 2005, 5:62.
26. Ling D.I., Zwerling A.A., Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 2008, 32:1165-1174.
27. Viveiros M., Leandro C., Rodrigues L., Almeida J., Bettencourt R., Couto I., Carrilho L., Diogo J., Fonseca A., Lito L., Lopes J., Pacheco T., Pessanha M., Quirim J., Sancho L., Salfinger M., Amaral L. Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J. Clin. Microbiol. 2005, 43:4880-4884.
28. Ajbani K., Shetty A., Mehta A., Rodrigues C. Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay. J. Clin. Microbiol. 2011, 49:2546-2551.
29. Blakemore R., Story E., Helb D., Kop J., Banada P., Owens M.R., Chakravorty S., Jones M., Alland D. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J. Clin. Microbiol. 2010, 48:2495-2501.
30. Boehme C.C., Nicol M.P., Nabeta P., Michael J.S., Gotuzzo E., Tahirli R., Gler M.T., Blakemore R., Worodria W., Gray C., Huang L., Caceres T., Mehdiyev R., Raymond L., Whitelaw A., Sagadevan K., Alexander H., Albert H., Cobelens F., Cox H., Alland D., Perkins M.D. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-1505.
31. Rosi N.L., Mirkin C.A. Nanostructures in biodiagnostics. Chem. Rev. 2005, 105:1547-1562.
32. Hauck T.S., Giri S., Gao Y., Chan W.C. Nanotechnology diagnostics for infectious diseases prevalent in developing countries. Adv. Drug Deliv. Rev. 2010, 62:438-448.
33. Weigl B., Domingo G., Labarre P., Gerlach J. Towards non- and minimally instrumented, microfluidics-based diagnostic devices. Lab Chip 2008, 8:1999-2014.
34. Liu Y., Sun Y., Sun K., Song L., Jiang X. Recent developments employing new materials for readout in lab-on-a-chip. J. Mater. Chem. 2010, 20:7305-7311.
35. Gubala V., Harris L.F., Ricco A.J., Tan M.X., Williams D.E. Point of care diagnostics: status and future. Anal. Chem. 2011, 84:487-515.
36. Niemz A., Boyle D.S. Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries. Expert. Rev. Mol. Diagn. 2012, 12:687-701.
37. Breadmore M.C., Wolfe K.A., Arcibal I.G., Leung W.K., Dickson D., Giordano B.C., Power M.E., Ferrance J.P., Feldman S.H., Norris P.M., Landers J.P. Microchip-based purification of DNA from biological samples. Anal. Chem. 2003, 75:1880-1886.
38. Wu Q., Jin W., Zhou C., Han S., Yang W., Zhu Q., Jin Q., Mu Y. Integrated glass microdevice for nucleic acid purification, loop-mediated isothermal amplification, and online detection. Anal. Chem. 2011, 83:3336-3342.
39. Christel L.A., Petersen K., McMillan W., Northrup M.A. Rapid, automated nucleic acid probe assays using silicon microstructures for nucleic acid concentration. J. Biomech. Eng. 1999, 121:22-27.
40. Lehmann U., Vandevyver C., Parashar V.K., Gijs M.A. Droplet-based DNA purification in a magnetic lab-on-a-chip. Angew. Chem. Int. Ed. Engl. 2006, 45:3062-3067.
41. Diaz-Quijada G.A., Peytavi R., Nantel A., Roy E., Bergeron M.G., Dumoulin M.M., Veres T. Surface modification of thermoplastics-towards the plastic biochip for high throughput screening devices. Lab Chip 2007, 7:856-862.
42. Notomi T., Okayama H., Masubuchi H., Yonekawa T., Watanabe K., Amino N., Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000, 28:E63.
43. Liu C., Mauk M.G., Hart R., Qiu X., Bau H.H. A self-heating cartridge for molecular diagnostics. Lab Chip 2011, 11:2686-2692.
44. Curtis K.A., Rudolph D.L., Nejad I., Singleton J., Beddoe A., Weigl B., LaBarre P., Owen S.M. Isothermal amplification using a chemical heating device for point-of-care detection of HIV-1. PLoS ONE 2012, 7:e31432.
45. Elghanian R., Storhoff J.J., Mucic R.C., Letsinger R.L., Mirkin C.A. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 1997, 277:1078-1081.
46. Myers F.B., Henrikson R.H., Bone J., Lee L.P. A handheld point-of-care genomic diagnostic system. PLoS ONE 2013, 8:e70266.
47. Haun J.B., Yoon T.J., Lee H., Weissleder R. Magnetic nanoparticle biosensors. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2:291-304.
48. Graham D.L., Ferreira H.A., Freitas P.P. Magnetoresistive-based biosensors and biochips. Trends Biotechnol. 2004, 22:455-462.
49. Ioannidis P., Papaventsis D., Karabela S., Nikolaou S., Panagi M., Raftopoulou E., Konstantinidou E., Marinou I., Kanavaki S. Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J. Clin. Microbiol. 2011, 49:3068-3070.
50. Inci F., Tokel O., Wang S., Gurkan U.A., Tasoglu S., Kuritzkes D.R., Demirci U. Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood. ACS Nano 2013, 7:4733-4745.
51. Kim Y.G., Moon S., Kuritzkes D.R., Demirci U. Quantum dot-based HIV capture and imaging in a microfluidic channel. Biosens. Bioelectron. 2009, 25:253-258.
52. Moon S., Gurkan U.A., Blander J., Fawzi W.W., Aboud S., Mugusi F., Kuritzkes D.R., Demirci U. Enumeration of CD4(+) T-cells using a portable microchip count platform in Tanzanian HIV-infected patients. PLoS ONE 2011, 6.
53. Shafiee H., Jahangir M., Inci F., Wang S., Willenbrecht R.B.M., Giguel F.F., Tsibris A.M.N., Kuritzkes D.R., Demirci U. Acute On-chip HIV Detection through Label-free Electrical Sensing of Viral Nano-lysate, Small 2013, (n/a-n/a).
54. Wang S., Xu F., Demirci U. Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol. Adv. 2010, 28:770-781.
55. Wang S.Q., Esfahani M., Gurkan U.A., Inci F., Kuritzkes D.R., Demirci U. Efficient on-chip isolation of HIV subtypes. Lab Chip 2012, 12:1508-1515.
56. Wang S.Q., Inci F., Chaunzwa T.L., Ramanujam A., Vasudevan A., Subramanian S., Ip A.C.F., Sridharan B., Gurkan U.A., Demirci U. Portable microfluidic chip for detection of Escherichia coli in produce and blood. Int. J. Nanomedicine 2012, 7:2591-2600.
57. Lee W.G., Kim Y.-G., Chung B.G., Demirci U., Khademhosseini A. Nano/microfluidics for diagnosis of infectious diseases in developing countries. Adv. Drug Deliv. Rev. 2010, 62:449-457.
58. Wang S., Sarenac D., Chen M.H., Huang S.-H., Giguel F.F., Kuritzkes D.R., Demirci U. Simple filter microchip for rapid separation of plasma and viruses from whole blood. Int. J. Nanomedicine 2012, 7:5019-5028.
59. Dheda K., Ruhwald M., Theron G., Peter J., Yam W.C. Point-of-care diagnosis of tuberculosis: past, present and future. Respirology 2013, 18:217-232.
60. Tasoglu S., Gurkan U.A., Wang S., Demirci U. Manipulating biological agents and cells in micro-scale volumes for applications in medicine. Chem. Soc. Rev. 2013, 42:5788-5808.
61. Wang H., Chen H.W., Hupert M.L., Chen P.C., Datta P., Pittman T.L., Goettert J., Murphy M.C., Williams D., Barany F., Soper S.A. Fully integrated thermoplastic genosensor for the highly sensitive detection and identification of multi-drug-resistant tuberculosis. Angew. Chem. Int. Ed. Engl. 2012, 51:4349-4353.
62. Liu D., Liang G., Zhang Q., Chen B. Detection of Mycobacterium tuberculosis using a capillary-array microsystem with integrated DNA extraction, loop-mediated isothermal amplification, and fluorescence detection. Anal. Chem. 2013, 85:4698-4704.
63. Liong M., Hoang A.N., Chung J., Gural N., Ford C.B., Min C., Shah R.R., Ahmad R., Fernandez-Suarez M., Fortune S.M., Toner M., Lee H., Weissleder R. Magnetic barcode assay for genetic detection of pathogens. Nat. Commun. 2013, 4:1752.
64. Roskos K., Hickerson A.I., Lu H.W., Ferguson T.M., Shinde D.N., Klaue Y., Niemz A. Simple system for isothermal DNA amplification coupled to lateral flow detection. PLoS ONE 2013, 8:e69355.
65. Fang X., Chen H., Xu L., Jiang X., Wu W., Kong J. A portable and integrated nucleic acid amplification microfluidic chip for identifying bacteria. Lab Chip 2012, 12:1495-1499.
66. Weigl B., Bardell R., Schulte T., Williams C. Passive microfluidics - ultra-low-cost plastic disposable lab-on-a-chips. Micro Total Analysis Systems 2000 2000, 299-302. Springer Netherlands. A. Berg, W. Olthuis, P. Bergveld (Eds.).
67. Weigl B., Bardell R., Schulte T., Battrell F., Hayenga J. Design and rapid prototyping of thin-film laminate-based microfluidic devices. Biomed. Microdevices 2001, 3:267-274.
68. Martinez A.W., Phillips S.T., Carrilho E., Thomas S.W., Sindi H., Whitesides G.M. Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for real-time, off-site diagnosis. Anal. Chem. 2008, 80:3699-3707.
69. Yetisen A.K., Akram M.S., Lowe C.R. Paper-based microfluidic point-of-care diagnostic devices. Lab Chip 2013, 13:2210-2251.
70. Veigas B., Jacob J.M., Costa M.N., Santos D.S., Viveiros M., Inacio J., Martins R., Barquinha P., Fortunato E., Baptista P.V. Gold on paper-paper platform for Au-nanoprobe TB detection. Lab Chip 2012, 12:4802-4808.
71. Veigas B., Machado D., Perdigao J., Portugal I., Couto I., Viveiros M., Baptista P.V. Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis. Nanotechnology 2010, 21:415101.
72. Zhu H., Isikman S.O., Mudanyali O., Greenbaum A., Ozcan A. Optical imaging techniques for point-of-care diagnostics. Lab Chip 2013, 13:51-67.
73. Gallegos D., Long K.D., Yu H., Clark P.P., Lin Y., George S., Nath P., Cunningham B.T. Label-free biodetection using a smartphone. Lab Chip 2013, 13:2124-2132.
74. Shafiee H., Lidstone E.A., Jahangir M., Inci F., Hanhauser E., Henrich T.J., Kuritzkes D.R., Cunningham B.T., Demirci U. Nanostructured optical photonic crystal biosensor for HIV viral load measurement. Sci. Rep. 2014, 4:4116.
75. Wang S., Tasoglu S., Chen P.Z., Chen M., Akbas R., Wach S., Ozdemir C.I., Gurkan U.A., Giguel F.F., Kuritzkes D.R., Demirci U. Micro-a-fluidics ELISA for rapid CD4 cell count at the point-of-care. Sci. Rep. 2014, 4:3796.
76. Granot Y., Ivorra A., Rubinsky B. A new concept for medical imaging centered on cellular phone technology. PLoS One 2008, 3:e2075.
77. Tokel O., Inci F., Demirci U. Advances in plasmonic technologies for point of care applications. Chem Rev. 2014, 10.1021/cr4000623.
78. Zimic M., Coronel J., Gilman R.H., Luna C.G., Curioso W.H., Moore D.A. Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries?. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:638-640.
79. Zimic M., Velazco A., Comina G., Coronel J., Fuentes P., Luna C.G., Sheen P., Gilman R.H., Moore D.A. Development of low-cost inverted microscope to detect early growth of Mycobacterium tuberculosis in MODS culture. PLoS ONE 2010, 5:e9577.
80. Xie H., Mire J., Kong Y., Chang M., Hassounah H.A., Thornton C.N., Sacchettini J.C., Cirillo J.D., Rao J. Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe. Nat. Chem. 2012, 4:802-809.
81. Kim J.H., Yeo W.H., Shu Z., Soelberg S.D., Inoue S., Kalyanasundaram D., Ludwig J., Furlong C.E., Riley J.J., Weigel K.M., Cangelosi G.A., Oh K., Lee K.H., Gao D., Chung J.H. Immunosensor towards low-cost, rapid diagnosis of tuberculosis. Lab Chip 2012, 12:1437-1440.
82. Lee H., Yoon T.J., Weissleder R. Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system. Angew. Chem. Int. Ed. Engl. 2009, 48:5657-5660.
83. Cira N.J., Ho J.Y., Dueck M.E., Weibel D.B. A self-loading microfluidic device for determining the minimum inhibitory concentration of antibiotics. Lab Chip 2012, 12:1052-1059.
84. Ho J.Y., Cira N.J., Crooks J.A., Baeza J., Weibel D.B. Rapid identification of ESKAPE bacterial strains using an autonomous microfluidic device. PLoS ONE 2012, 7:e41245.
85. Funes-Huacca M., Wu A., Szepesvari E., Rajendran P., Kwan-Wong N., Razgulin A., Shen Y., Kagira J., Campbell R., Derda R. Portable self-contained cultures for phage and bacteria made of paper and tape. Lab Chip 2012, 12:4269-4278.
86. Deiss F., Funes-Huacca M.E., Bal J., Tjhung K.F., Derda R. Antimicrobial susceptibility assays in paper-based portable culture devices. Lab Chip 2014, 14:167-171.
87. Sheridan C. Milestone approval lifts Illumina's NGS from research into clinic. Nat. Biotechnol. 2014, 32:111-112.
88. Metzker M.L. Applications of next-generation sequencing technologies - the next generation. Nat. Rev. Genet. 2010, 11:31-46.
89. Mabey D., Peeling R.W., Ustianowski A., Perkins M.D. Diagnostics for the developing world. Nat. Rev. Microbiol. 2004, 2:231-240.
90. Saunders N.J., Trivedi U.H., Thomson M.L., Doig C., Laurenson I.F., Blaxter M.L. Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. J. Infect. 2011, 62:212-217.
91. Durmus N.G., Taylor E.N., Inci F., Kummer K.M., Tarquinio K.M., Webster T.J. Fructose-enhanced reduction of bacterial growth on nanorough surfaces. Int. J. Nanomedicine 2012, 7:537-545.